PURPOSE: To assess the prognostic value of symptoms in hospitalised advanced cancer patients. PATIENTS AND METHODS: A prospective analysis was performed of 181 hospitalised patients referred to a Palliative Care Team. Comprehensive symptom questionnaire, functional status, estimated life expectancy and survival were assessed. Using a Cox regression model, a predictive survival model was built. RESULTS: Median survival: 53 d. Median number of symptoms: 4; 20 symptoms occurred in 10%. Multivariate analysis showed nausea, dysphagia, dyspnoea, confusion and absence of depressed mood as independent prognostic factors for survival (p<0.05) with relative risks of dying of 1.96, 1.81, 1.79, 2.35 and 1.79, respectively. Patients with 2, 3 or 4 of these factors at the same time had a relative risk of dying of 2.7, 2.1 and 9.0, respectively. CONCLUSION: A cluster of factors comprising nausea, dysphagia, dyspnoea, confusion and absence of depressed mood may be used to accurately predict survival in hospitalised advanced cancer patients.
PURPOSE: To assess the prognostic value of symptoms in hospitalised advanced cancerpatients. PATIENTS AND METHODS: A prospective analysis was performed of 181 hospitalised patients referred to a Palliative Care Team. Comprehensive symptom questionnaire, functional status, estimated life expectancy and survival were assessed. Using a Cox regression model, a predictive survival model was built. RESULTS: Median survival: 53 d. Median number of symptoms: 4; 20 symptoms occurred in 10%. Multivariate analysis showed nausea, dysphagia, dyspnoea, confusion and absence of depressed mood as independent prognostic factors for survival (p<0.05) with relative risks of dying of 1.96, 1.81, 1.79, 2.35 and 1.79, respectively. Patients with 2, 3 or 4 of these factors at the same time had a relative risk of dying of 2.7, 2.1 and 9.0, respectively. CONCLUSION: A cluster of factors comprising nausea, dysphagia, dyspnoea, confusion and absence of depressed mood may be used to accurately predict survival in hospitalised advanced cancerpatients.
Authors: J J Koldenhof; P O Witteveen; R de Vos; M Walraven; C N Tillier; H M W Verheul; S C C M Teunissen Journal: Support Care Cancer Date: 2014-04-02 Impact factor: 3.603
Authors: Debra K Moser; Kyoung Suk Lee; Jia-Rong Wu; Gia Mudd-Martin; Tiny Jaarsma; Tsuey-Yuan Huang; Xui-Zhen Fan; Anna Strömberg; Terry A Lennie; Barbara Riegel Journal: Int J Nurs Stud Date: 2014-02-28 Impact factor: 5.837
Authors: Vithusha Ganesh; Liying Zhang; Stephanie Chan; Bo Angela Wan; Leah Drost; May Tsao; Cyril Danjoux; Elizabeth Barnes; Rachel McDonald; Leigha Rowbottom; Pearl Zaki; Ronald Chow; Matthew K Hwang; Carlo DeAngelis; Nicholas Lao; Edward Chow Journal: Support Care Cancer Date: 2017-05-23 Impact factor: 3.603
Authors: Frederieke H van der Baan; Josephine J Koldenhof; Ellen J de Nijs; Michael A Echteld; Danielle Zweers; Ginette M Hesselmann; Sigrid C Vervoort; Jan B Vos; Everlien de Graaf; Petronella O Witteveen; Karijn P Suijkerbuijk; Alexander de Graeff; Saskia C Teunissen Journal: Cancer Med Date: 2020-07-09 Impact factor: 4.452